MENU
+Compare
ALKS
Stock ticker: NASDAQ
AS OF
Sep 5 closing price
Price
$29.94
Change
+$1.02 (+3.53%)
Capitalization
4.94B

ALKS Alkermes plc Forecast, Technical & Fundamental Analysis

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ALKS with price predictions
Sep 04, 2025

ALKS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for ALKS turned positive on August 07, 2025. Looking at past instances where ALKS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ALKS moved above its 50-day moving average on August 19, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ALKS crossed bullishly above the 50-day moving average on August 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALKS advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 215 cases where ALKS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where ALKS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALKS as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALKS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ALKS broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ALKS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.042) is normal, around the industry mean (19.044). P/E Ratio (14.464) is within average values for comparable stocks, (73.931). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.885). ALKS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (3.331) is also within normal values, averaging (42.427).

View a ticker or compare two or three
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALKS is expected to report earnings to fall 22.94% to 40 cents per share on October 22

Alkermes plc ALKS Stock Earnings Reports
Q3'25
Est.
$0.40
Q2'25
Beat
by $0.16
Q1'25
Missed
by $0.18
Q4'24
Beat
by $0.30
Q3'24
Beat
by $0.01
The last earnings report on July 29 showed earnings per share of 51 cents, beating the estimate of 36 cents. With 2.50M shares outstanding, the current market capitalization sits at 4.94B.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIRCX78.740.41
+0.52%
American Funds Capital Income Bldr 529C
MEFAX13.30N/A
N/A
MassMutual Mid Cap Growth A
RPMMX17.65N/A
N/A
Reinhart Mid Cap PMV Inv
HMVTX18.45N/A
N/A
Hartford MidCap Value R5
FLDGX14.92-0.01
-0.07%
Meeder Dynamic Allocation Retail

ALKS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+3.53%
AMRX - ALKS
39%
Loosely correlated
+0.73%
COLL - ALKS
36%
Loosely correlated
-2.32%
PCRX - ALKS
33%
Loosely correlated
-1.05%
PRGO - ALKS
33%
Poorly correlated
-2.75%
DVAX - ALKS
32%
Poorly correlated
+0.80%
More

Groups containing ALKS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
+3.53%
Pharmaceuticals: Generic
industry (223 stocks)
13%
Poorly correlated
+2.48%